The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.

PubWeight™: 0.81^‹?›

🔗 View Article (PMID 25554382)

Published in Antiviral Res on December 29, 2014

Authors

Yahira M Báez-Santos¹, Sarah E St John¹, Andrew D Mesecar²

Author Affiliations

1: Department of Biological Sciences, Purdue University, West Lafayette, IN, USA; Department of Chemistry, Purdue University, West Lafayette, IN, USA; Center for Drug Discovery, Purdue University, West Lafayette, IN, USA; Center for Cancer Research, Purdue University, West Lafayette, IN, USA.
2: Department of Biological Sciences, Purdue University, West Lafayette, IN, USA; Department of Chemistry, Purdue University, West Lafayette, IN, USA; Center for Drug Discovery, Purdue University, West Lafayette, IN, USA; Center for Cancer Research, Purdue University, West Lafayette, IN, USA. Electronic address: amesecar@purdue.edu.

Associated clinical trials:

Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260

Articles citing this ↘

Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov (2016) 0.91

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme. Biochem J (2015) 0.83

Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses. J Virol (2016) 0.80

p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A (2016) 0.76

Coronaviruses and the human airway: a universal system for virus-host interaction studies. Virol J (2016) 0.75

X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design. Sci Rep (2017) 0.75